- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01599533
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm
November 28, 2019 updated by: Assistance Publique Hopitaux De Marseille
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm : Prevalence, Description of the Different Thoracic Aortic Phenotypes by Aortic Volumetric Numerized Imaging and Their Relationship With Epidemiologic, Clinical, Biological and Genetic Factors
Many publications deal with the natural history of aortic aneurysms in literature.
Except for connective tissue disorders as Marfan or Loeys-Dietz syndrome, aortic aneurysms are a complex multifactorial disease with genetic and environmental risk factors.
Susceptibility loci identified in thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA) do not overlap, suggesting that different genetic risk factors contribute to these two forms of aneuryms.
With a higher prevalence correlated to ageing (5%), AAA is usually presented as the degenerative form of the disease.
However, a recent epidemiologic study by Olsson et al. has revealed an increasing incidence of thoracic aortic disease among older individuals (70+/-12 years) with 60% of aneurysmal rupture or dissection at diagnosis, and a 1.7 :1 male-to-female ratio compared to 6:1 in AAA.
From this current knowledge arises the concept of diffuse or plurisegmental degenerative aneurysmal aortic disease, poorly explored so far.
As regards to the prevention policy, there is a consensus statement in which ultrasonography screening for AAA is recommended for all individuals aged > 60 years (particularly in men who have ever smoked) and for those aged > 50 years with family history of AAA.
Nevertheless, screening for a concomittant thoracic location of the disease (except thoracoabdominal aneurysm) is not yet required, whereas it could change the prognosis of the patients and influence their management.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Through the constitution of a multicentric prospective cohort of patients with infra-renal AAA (n=450), the investigators aimed to determine the prevalence of a concomitant TAA, and the epidemiologic, clinical, biological and genetic factors related to this aortic phenotype.
Therefore, the investigators postulate for a prevalence of the AAA-TAA association inferior or equal to 15%.
By the use of an innovating software (AMIRA) to analyse scans, the investigators will perform reproductive measurements of segmental diameters from a segmental aortic volumetric numerized imaging, and describe the different thoracic aortic phenotypes associated with AAA, including the form (TAA, penetrating ulcer, dolichoaorta …) and the location of the disease.
Study Type
Interventional
Enrollment (Actual)
345
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Major subject at the time of the inclusion
- Subject sent in hospitalization or in consultation of surgery vascular for coverage of the first one anévrysme of the sub-renal abdominal aorta degenerative, without anomaly associated by the coeliac aorta, and by the upper diameter in 40mm (according to the criteria of measure recommended for the analysis in echography doppler or in angioscanner).
- subject not presenting contraindication to the realization of the diagnostic examination by aortic angioscanner
- Subject having signed a consent.
Exclusion Criteria:
Subject under age 18
- pregnant Woman
- Subject received in the phase aigue of a break or a fissuring of an AAA under renal
- Subject already operated for a thoracic or abdominal aortic anévrysme
- Subject presenting at least one of the following pathologies:
- heart disorder valvulaire aortic: aortic incapacity of rank superior to 2, tight aortic stenosis, prosthesis valvulaire aortic
- context of bicuspidie station wagon diagnosed on at least 2 parents of the first degree
- of a not degenerative aortopathie anévrysmale bound(connected) in bicuspidie aortic, or: A dissection of type(chap) A or of type(chap) B
- Of a degenerative aortopathie of type anévrysme thoracoabdominal (in particular, affected by the coeliac aorta, defined by the segment enter the diaphragmatique crossing and the renal arteries)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: abdominal aortic aneurysms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BLOOD SAMPLES
Time Frame: 3 YEARS
|
to determine the prevalence thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA)
|
3 YEARS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ANGIOSCAN
Time Frame: 3 YEARS
|
the validation of volumetric criteria to quantify the aortic remodeling in TAA or untreated AAA
|
3 YEARS
|
|
CARDIAC STATEMENT
Time Frame: 3 YEARS
|
cardiac echography
|
3 YEARS
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2012
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2018
Study Registration Dates
First Submitted
April 10, 2012
First Submitted That Met QC Criteria
May 14, 2012
First Posted (Estimate)
May 16, 2012
Study Record Updates
Last Update Posted (Actual)
December 2, 2019
Last Update Submitted That Met QC Criteria
November 28, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-A00042-41
- 2012-01 (AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysms
-
Steven MaximusBaylor College of MedicineRecruitingAbdominal Aortic Aneurysms | Pararenal Aortic Aneurysm | Thoracoabdominal AneurysmsUnited States
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac AneurysmsUnited States, Canada
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States, China, Germany, Sweden, Russian Federation
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Group IncorporatedNo longer availableAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
Cook Group IncorporatedApproved for marketingAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Rijnstate HospitalW.L.Gore & AssociatesCompletedAneurysm | Abdominal Aortic Aneurysms | Common Iliac AneurysmsItaly, New Zealand, Netherlands, Spain
-
Prouse GiorgioRecruitingComplex Abdominal Aortic AneurysmsSwitzerland
-
Endospan Ltd.CompletedAortoiliac Aneurysms | Infrarenal Abdominal Aortic AneurysmsItaly, Serbia, Netherlands, Switzerland
-
iVascular S.L.U.RecruitingComplex Abdominal Aortic AneurysmsGermany, Belgium, Netherlands, France, Spain
Clinical Trials on blood samples
-
Centre Georges Francois LeclercINSERM U866 Faculté de Médecine et PharmacieCompleted
-
Centre Hospitalier Universitaire DijonCompletedPrimary Immune Thrombocytopenia (ITP)France
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPaediatric MalignanciesFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Assistance Publique Hopitaux De MarseilleRecruitingPlastic SurgeriesFrance
-
Assiut UniversityCompleted
-
Ain Shams UniversityCompletedUrinary Tract Infection Bacterial | Pneumonia - Bacterial | All Conditions Causing SepsisEgypt
-
University Hospital, AngersRecruiting
-
Centre Hospitalier Universitaire DijonRecruiting
-
Assistance Publique Hopitaux De MarseilleRecruitingLeukaemia During Childhood or AdolescenceFrance